All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
For patients who are newly diagnosed with Fibromyalgia (FMS) within 18 months or an established diagnosis of FMS.
Non-malignant generalised pain unresponsive to simple analgesia.
Pain lasting more than three months.
Patients with escalating drug requirements and/or lengthy sickness absence.
This pathway is not for patients with a singular diagnosis of CFS/ME.
Fibromyalgia causes widespread pain and tenderness. The pain and tenderness tend to come and go, and move about the body.
It is usually associated with poor sleep and is strongly associated with migraine and irritable bowel syndrome.
Assess:
History
Widespread pain for at least three months.
Examination
General physical examination including neurological, musculoskeletal to exclude signs of synovitis, mental state assessment. No need to confirm tender points.
Confirm diagnosis
Using either the Fibromyalgia diagnostic criteria or Quick Guide to Fibromyalgia Scoring tools determine whether diagnosis is confirmed. Exclude other conditions that may present with widespread pain.
Rheumatological symptoms, including early morning stiffness, joint swelling or small joint pain.
Pain with fever, weight loss, lymphadenopathy, visual or neurological disturbance.
Pain associated with or related to cancer diagnosis (use 2 week pathway).
Pain with abnormal blood or urine results (raised ESR/anaemia/proteinuria/haematuria).
Please consider the following investigations to exclude other diagnoses, for example (but not limited to):
(N.B. In suspected cases of FMS there is no indication for auto antibody testing e.g. ANA. These tests should only be done when patient have specific CTD symptoms (e.g. Raynaud’s, sicca symptoms etc)
• Please see Investigations | Diagnosis | Chronic pain | CKS | NICE for further details.
Confirm diagnosis:
Using either the Fibromyalgia diagnostic criteria or Quick Guide to Fibromyalgia Scoring tools determine whether diagnosis is confirmed. Exclude other conditions that may present with widespread pain.
A diagnosis of Fibromyalgia does not mean it is the patient's only diagnosis or even the most important diagnosis. New symptoms and signs should be investigated as appropriate.
Provide Moving Forward with Fibromyalgia leaflet so the patient can opt-in to the pathway and education seminars.
If patient is not suitable for the education seminars and requires a specialist opinion please either seek advice via advice and guidance (A&G) or refer.
Include investigations undertaken to support diagnosis
e-Referral Service Selection
Reconnect2Life is an interactive programme to help patients look at their pain and how it affects them. It consists of six programme modules plus provides information on seminars and short courses which are run locally.
Sharing this resource with patients will help them understand and manage their pain better.
Reconnect2life website – patient information
This guideline has been signed off on behalf of NHS Devon.
Dr Lyn Margetts – Consultant in Pain Management
Ms Phillipa Newton-Cross – Clinical Lead Physiotherapist in Pain Rehabilitation
Dr Becky Chasey – Lead Clinical Psychologist for the Pain Management Team
Dr Eileen Deakin – GP and Clinical Lead for Long Term Conditions
Publication date: October 2017
Updated: January 2024